68 followers
Letter: Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate https://t.co/TyRlPTWJf3
Letter: Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate https://t.co/TyRlPTWJf3
New article: Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate https://t.co/Qr96F6Jsak #prostatecancer #oncology https://t.co/Oidf7R6Qe4